Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life: An open, randomized controlled trial (Q40329667)
Jump to navigation
Jump to search
scientific article published on 6 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life: An open, randomized controlled trial |
scientific article published on 6 April 2011 |
Statements
1 reference
Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life: An open, randomized controlled trial (English)
1 reference
Timo Vesikari
1 reference
Aino Karvonen
1 reference
Veronique Bianco
1 reference
Marie Van der Wielen
1 reference
Jacqueline Miller
1 reference
6 April 2011
1 reference
1 reference
29
1 reference
25
1 reference
4274-4284
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference